Lion Street Advisors, LLC Cardiol Therapeutics Inc. Transaction History
Lion Street Advisors, LLC
- $266 Million
- Q2 2024
A detailed history of Lion Street Advisors, LLC transactions in Cardiol Therapeutics Inc. stock. As of the latest transaction made, Lion Street Advisors, LLC holds 253,281 shares of CRDL stock, worth $501,496. This represents 0.19% of its overall portfolio holdings.
Number of Shares
253,281
Previous 192,700
31.44%
Holding current value
$501,496
Previous $348,000
46.84%
% of portfolio
0.19%
Previous 0.13%
Shares
2 transactions
Others Institutions Holding CRDL
# of Institutions
45Shares Held
5.47MCall Options Held
162KPut Options Held
7.4K-
Tejara Capital LTD London, X01.72MShares$3.41 Million1.26% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD1.47MShares$2.9 Million0.55% of portfolio
-
Mmcap International Inc. Spc Grand Cayman, E9924KShares$1.83 Million0.36% of portfolio
-
Cambridge Investment Research Advisors, Inc.116KShares$229,9390.0% of portfolio
-
Knoll Capital Management, LLC Miami, FL100KShares$198,0000.14% of portfolio
About Cardiol Therapeutics Inc.
- Ticker CRDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 61,942,500
- Market Cap $123M
- Description
- Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...